Skip to main content

Change in PDL Status for the Bronchodilators, Beta Agonist Drug Class Effective January 3, 2025

Last updated on

On January 3, 2025, the Texas Health and Human Services Commission (HHSC) removed the non-preferred status from the generic levalbuterol inhalation solution on the HHSC preferred drug list (PDL). This change is in response to the discontinuation of inhalation solution products with the preferred brand name Xopenex.

The non-preferred status of the following drugs was removed:

National Drug Code (NDC)Drug Name
00093414556Levalbuterol 0.31 mg/3 ml solution
00115993078Levalbuterol 0.31 mg/3 ml solution
00378969052Levalbuterol 0.31 mg/3 ml solution
35573044325Levalbuterol 0.31 mg/3 ml solution
47335074349Levalbuterol 0.31 mg/3 ml solution
65862094324Levalbuterol 0.31 mg/3 ml solution
76204070001Levalbuterol 0.31 mg/3 ml solution
76204070025Levalbuterol 0.31 mg/3 ml solution
00115993178Levalbuterol 0.63 mg/3 ml solution
00378969152Levalbuterol 0.63 mg/3 ml solution
00093414656Levalbuterol 0.63 mg/3 ml solution
35573044425Levalbuterol 0.63 mg/3 ml solution
47335074649Levalbuterol 0.63 mg/3 ml solution
65862094424Levalbuterol 0.63 mg/3 ml solution
76204080001Levalbuterol 0.63 mg/3 ml solution
76204080025Levalbuterol 0.63 mg/3 ml solution
00093414856Levalbuterol 1.25 mg/3 ml solution
00115993278Levalbuterol 1.25 mg/3 ml solution
00378969252Levalbuterol 1.25 mg/3 ml solution
35573044525Levalbuterol 1.25 mg/3 ml solution
47335075349Levalbuterol 1.25 mg/3 ml solution
65862094524Levalbuterol 1.25 mg/3 ml solution
76204090001Levalbuterol 1.25 mg/3 ml solution
76204090025Levalbuterol 1.25 mg/3 ml solution
00378699393Levalbuterol concentrate 1.25 mg/0.5 ml solution

These changes allow providers to prescribe the generic levalbuterol inhalation solution products without requiring PDL prior authorization. 

Email vdp-formulary@hhsc.state.tx.us with any questions.